Unlock instant, AI-driven research and patent intelligence for your innovation.
Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of complexes and bisphosphonates, applied in the fields of radiopharmaceuticals and nuclear medicine, can solve problems such as no reports, and achieve good results
Inactive Publication Date: 2005-10-12
JIANGSU INST OF NUCLEAR MEDICINE
View PDF1 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
But with technetium-99m ( 99m Tc) labeled zoled
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0029] 1) Preparation of technetium-99m zoledronic acid complex
[0030] In a 10ml vial, add 3-5mg of zoledronic acid, SnCl 2 2H 2 O hydrochloric acid solution 0,05 ~ 0.2mL (the concentration of hydrochloric acid is 1mol L -1 , containing 2.5g·L -1 SnCl 2 2H 2 O), after shaking well, use phosphate buffer solution (pH8.0) to adjust the pH to 5-7, add freshly rinsed pertechnetium-99m acid ( 99m TCO4 - ) solution of 18.5 to 185 megabeq (MBq), fully mixed, placed at room temperature for 5 to 10 minutes, and the labeling is completed, the technetium-99m labeled zoledronic acid complex of the present invention ( 99m Tc-ZL).
[0031] 2) Determination of labeling rate of technetium-99m zoledronic acid complex
[0032] The labeling rate of the technetium-99m zoledronic acid complex refers to the percentage of the radioactivity of the technetium-99m zoledronic acid complex in...
[0040] In a 10ml vial, add 3-5 mg of 2-(2-methylimidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid, SnCl 2 2H 2 O hydrochloric acid solution 0.05 ~ 0.2mL (the concentration of hydrochloric acid is 1mol L -1 , containing 2.5g·L -1 SnCl 2 2H 2 O), after shaking well, use phosphate buffer solution (pH8.0) to adjust the pH to 5-7, add freshly rinsed pertechnetium-99m acid ( 99m TCO 4 - ) solution of 18.5 to 185 megabeq (MBq), fully mixed, and placed at room temperature for 5 to 10 minutes to obtain the technetium-99m labeled 2-(2-methylimidazol-1-yl)-1 -Hydroxyethane-1,1-diphosphonic acid complex (99mTc-MZL).
[0041] 2) 99m Determination of Tc-MZL labeling rate
[0042] Adopt HPLC method to measure: adopt U.S. Varian 5000 type HPLC instrument, chromatographic column is C...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
Diphosphate complex of ZL phosphonic acid with radioactive technetium-99m mark and its production are disclosed. Diphosphate of ZL phosphonic acid is 2-(imidazole-1-radical)-1-hydroxyl ethane-1, 1-di-(2-ethylhexyl)phosphoric acid ZL phosphonic acid , ZL), 2-(2-methyl imidazole-1-radical)-1-hydroxyl ethane-1, and 1-diphosphate(MZL). It is carried out by combining diphosphate(ZL or MZL) of ligand ZL phosphonic acid and reducer with pH buffering agent to be medicine pack, adding pertechnetate(99mTcO4-) solution into medicine pack, reacting, and obtaining diphosphate complex 99mTc-ZL or 99mTc-MZL of ZL phosphonic acid with radioactive technetium-99m mark. It can be used for nuclear medical diagnostic image or treat rheumatoid disease and tumor.
Description
technical field [0001] The bisphosphonic acid complex of radioactive technetium-99m labeled zoledronic acid and its preparation method relate to the fields of radiopharmaceuticals and nuclear medicine. Background technique [0002] The main inorganic salt component of bone is hydroxyapatite crystal, which has a structure similar to ion exchange column and has a large surface area. It obtains phosphate and other elements from blood through chemical adsorption and ion exchange to complete metabolic renewal. Radiopharmaceuticals such as technetium-99m[ 99m Tc]-phosphonate is quickly adsorbed and deposited on the surface of hydroxyapatite crystals in bones after intravenous injection, which specifically shows the metabolism of bones. When there are local bone lesions, such as inflammation, tumor, fracture, etc. causing changes in local blood flow and / or bone inorganic salt metabolism, abnormally increased radioactivity will be displayed in the corresponding parts. These abnorma...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.